Although it has been suggested that ‘dirty drugs’ (with multiple actions) could be a solution [497], it is very difficult to treat a single AD pathology (amyloid, tau), and a combined treatment against several associated brain pathologies (AD, vascular lesions, TDP43) seems to be a much more difficult task. Here, MAPT is linked to Alzheimer disease.